GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.92+0.05 (+2.95%)
Close on Nov 16, 2026Market cap $86.87MP/E –Yield –
Genelux profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Genelux's profit margin for the twelve months ending Dec 31, 2024 was -373362.5%. For fiscal 2025 it was -401812.5%, against -373362.5% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -401812.5% | −28450.0 |
| FY2024 | Dec 31, 2024 | -373362.5% | −356717.2 |
| FY2023 | Dec 31, 2023 | -16645.3% | −16598.2 |
| FY2022 | Dec 31, 2022 | -47.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -98125.0% | – |
| Q1 FY2023 | Mar 31, 2023 | -6096.5% | – |
| Q4 FY2022 | Dec 31, 2022 | -5139.7% | – |
| Q3 FY2022 | Sep 30, 2022 | 44.6% | – |
See a number that looks wrong?